We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Deep Learning Advances Breast Cancer Ultrasound Algorithm

By HospiMedica International staff writers
Posted on 16 Jun 2016
A novel computer-aided diagnosis (CADx) solution for ultrasound is based on deep learning from an independently acquired anonymous set of real-life data.

Developed at Samsung (Seoul, Korea), the innovative S-Detect for Breast CADx algorithm is based on a database of over 10,000 anonymous breast ultrasound images and decades worth of clinical experience from partnering medical institutes and doctors, such as Samsung Medical Center (SMC; Seoul, South Korea). More...
The deep-learning algorithm uses the standardized Breast Imaging-Reporting and Data System (BI-RADS) score for analysis and classification of targeted regions.

The user simply touches a seed point on the touch screen and the S-Detect automatically sets lesion boundaries, providing multiple images; the BI-RADS score is automatically displayed. The intelligent technology then helps to determine the size and shape of the lesions, gives advice on whether they are benign or malignant, and integrates all that information into a single report that aids in effective diagnosis and reduction of unnecessary biopsies.

The S-Detect algorithm is already incorporated into an upgraded version of the Samsung RS80A with Prestige ultrasound device, offering standardized analysis and classification of suspicious lesions. It includes three modes to set the level of sensitivity and specificity requiered. The RS80A also provides E-Breast elastography technology to calculates the strain ratio for thyroid lesions, and contrast-Enhanced Ultrasound (Low-MI) to process reflected signals from contrast agents, stimulated by particular ultrasound pulses, which produce a unique sonogram with increased contrast.

While final diagnosis and decisions are made by doctors, the S-Detect for Breast can equip them with the knowledge to help them make better decisions faster. Samsung announced that the Samsung Advanced Institute of Technology (SAIT) will conduct further work with partnering medical institutes such as SMC to further improve the S-Detect algorithm and to expand application of the technology to other areas of ultrasound diagnosis, such as the thyroid, liver, and more.

Related Links:
Samsung
Samsung Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.